CITIGROUP INC: K position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITIGROUP INC on K, newest first. How the timeline and the estimate are built.
CITIGROUP INC held 0 K shares at 2025-12-31 per its 13F-HR filed 2026-02-13.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -454,906 shares
13F-HR 0000831001-26-000006 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 454,906 sharesChange vs previous 13F -134,815 shares
0.03% of the 13F portfolio, value $37,311,429.
13F-HR 0000831001-25-000158 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 589,721 sharesChange vs previous 13F +132,583 shares
0.03% of the 13F portfolio, value $46,900,549.
13F-HR 0000831001-25-000145 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 457,138 sharesChange vs previous 13F +230,397 shares
0.03% of the 13F portfolio, value $37,709,353.
13F-HR 0000831001-25-000103 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 226,741 sharesChange vs previous 13F -96,878 shares
0.02% of the 13F portfolio, value $18,359,257.
13F-HR 0000831001-25-000062 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 323,619 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $26,119,328.
13F-HR 0000831001-24-000148 filed by CITIGROUP INC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).